Pancreatic cancer remains one of the most difficult malignancies to diagnose and treat, largely because early-stage disease is often asymptomatic. Despite decades of research, outcomes for patients with metastatic pancreatic ductal adenocarcinoma have remained poor, with limited treatment options available after first-line therapy fails. Current imaging modalities frequently fail to…

The traditional clinical trial model characterized by discrete phases, manual data entry, and the long “hiatus” between database lock and regulatory review is officially entering the archives. On April 28, 2026, the FDA unveiled a landmark initiative to implement Real-Time Clinical Trials (RTCT), moving the industry toward a model of…

The landscape of clinical trials is undergoing a fundamental transformation. As we move through 2026, the traditional benchmarks of success for a clinical research site-once defined solely by recruitment numbers and paper-heavy documentation are being replaced by a new paradigm of Artificial Intelligence (AI) integration and high-level clinical synthesis. The…